Latest news with #NipponExpress
Forbes
4 days ago
- Business
- Forbes
Expanding Horizons: NX Group's Role In Global Logistics
In recent years, pandemic-related port closures, the conflict in Ukraine and now the threat of new U.S. tariffs have resulted in significant challenges to global supply chains. But behind the scenes, logistics companies are ensuring that important shipments are getting to where they need to be on time. One of them is NX Group, which is leveraging leading-edge technology and strategic acquisitions to establish itself as one of the top five players in the international freight industry. NIPPON EXPRESS HOLDINGS President Satoshi Horikiri talks about the company's growth in the global market. NIPPON EXPRESS HOLDINGS President Satoshi Horikiri aims to make NX Group one of the top five players in the international freight industry. A Foundation Built on Trust and Technological Advances Established in 1937, Nippon Express, the core company of NX Group, has roots that go back to 1872, a time when Japan began a rapid program of modernization. The company was founded by merging rail and other transport companies, immediately giving it a multimodal advantage. After quickly expanding across Japan and internationally, mainly in B2B logistics, NX Group built a reputation as a precision-oriented, flexible partner trustworthy enough to ship masterpieces like the Mona Lisa and the Venus de Milo around the world. As of 2023, NX Group has a significant 25% share of Japan's air exports, and is currently ranked 8th in air freight, 6th in sea freight and 6th overall. 'Our strength lies in our leading presence in Asia, with Japan as the core of our operations,' says Horikiri. 'Asia accounts for a significant portion of global cargo volume, with some 60–70% of global cargo originating from the region. Another source of strength is our combination of freight forwarding and logistics. Based on account management, we can provide the right solution for every customer.' NX Group has introduced warehouse AI and cloud-connected autonomous mobile robots that transport inventory to loading bays. Supporting this position is NX Group's deployment of leading-edge logistics technology. It has introduced warehouse AI and cloud-connected autonomous mobile robots (AMRs) that transport inventory to loading bays. NX Group has established systems that provide real-time cargo tracking and digital monitoring of temperature and impact on cargo, as well as forklifts with remote, autonomous and manual operating modes. 'We have started a pilot project called the NX Universal Harmonious Work Warehouse, a place where people of all abilities can work in a supportive environment that incorporates short-distance mobility solutions. This is the first phase of a workplace evolution to create a better environment for everyone,' says Horikiri. 'I believe these innovations have boosted distribution efficiency and helped NX Group better serve its customers.' NX Group has started a pilot project called the NX Universal Harmonious Work Warehouse, where people of all abilities can work while using short-distance mobility solutions. Leveraging M&As to Fuel Customer Growth With a focus on key industries, including semiconductor, healthcare and automotive, NX Group now includes over 300 companies and more than 78,000 employees working in 57 countries and regions all over the world. Over the past decade, NX Group, which values a customer-oriented approach, has grown into a company that can create even greater value by attracting companies with the same philosophy to join the group. 'The goal of this strategy is not only to increase global scale but also to support customers as they enter new markets,' says Horikiri. 'Mergers and acquisitions increase purchasing power for transportation, leading to expanded capabilities and more solutions for customer challenges.' One example is expanding a network in Eastern Europe and a customer base outside Japan. In 2024, NIPPON EXPRESS HOLDINGS acquired cargo-partner, an Austrian logistics company with a strong presence in Central and Eastern Europe. Established in 1983, cargo-partner specializes in air and ocean freight forwarding and offers services in rail and truck transportation, as well as contract logistics. NX Group now includes over 300 companies and more than 78,000 employees working in 57 countries and regions all over the world. Commenting on the value of this acquisition Horikiri says, 'It brings key synergies: a strong transportation network in Central and Eastern Europe, complementary customer bases for cross-selling and enhanced efficiency through combined cargo volumes, integrated operations and shared back-office functions.' In another example aimed at increasing competitiveness and efficiency, NIPPON EXPRESS HOLDINGS acquired the Simon Hegele Group, a German contract logistics provider, in 2025. Founded in 1920, Simon Hegele specializes in logistics services for the healthcare industry and has over 2,800 employees and operations across Europe, the U.S., South America, Asia and Australia. 'Simon Hegele has built a robust customer base by leveraging its specialized logistics platform,' says Horikiri. 'It has strength in healthcare and transportation networks within the EU. By integrating with NX Group's forwarding functions, it will create synergies and provide end-to-end services from transportation to delivery and installation.' 'Cargo-partner and Simon Hegele are very customer-oriented companies whose corporate culture resonates with our DNA,' Horikiri says. 'We're confident that the service and quality we have built in Japan, our home market, will be welcomed by Western companies. Recently, foreign companies that used our services in Japan really liked them and expressed a desire to use them globally.' As NX Group brings its Japanese sensibility of attention to detail, precision logistics and innovative end-to-end solutions to serve a broader scale of businesses overseas, it will leverage both its technological expertise and its ability to deal with the unexpected. 'M&As increase purchasing power for transportation, leading to expanded capabilities and more solutions for customer challenges,' says Horikiri. Maintaining Focus on Customer-Oriented Solutions Recently, due to geopolitical risks, flying over Russia and sailing through the Red Sea have become challenging. Even outside of conflict zones, there are cases where regulations in various countries are suddenly tightened, or domestic disasters cut off roads. Logistics is a global industry, and irregular situations occur constantly. "NX Group's motto, 'We find the way,' reflects the company's commitment to overcoming logistics challenges and providing optimal solutions tailored to each individual customer," says Horikiri. "It shows our commitment to finding the best transportation solutions, meeting our customers' challenges and seeing them through. This customer-centric approach is what drives NX Group's global business expansion and enables us to provide high-quality services that are closely aligned with our customers' needs." To learn more about NX Group, click here.
Yahoo
19-05-2025
- Business
- Yahoo
NIPPON EXPRESS HOLDINGS Completes Stock Acquisition of Cold Chain Bangladesh Limited
TOKYO, May 19, 2025 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, Inc. is pleased to announce that through its subsidiary, Nippon Express (South Asia & Oceania) Pte. Ltd., it has acquired a 20% shareholding in Cold Chain Bangladesh Limited (hereafter "CCBL"), a logistics company engaged in domestic logistics operations in Bangladesh. The acquisition took place on May 15, 2025. NX Logo: Photo of Ahmed Rajeeb Samdani (left), a shareholder of CCBL, and Katsuhito Kobayashi, President of Nippon Express (South Asia & Oceania) Pte. Ltd.: The NX Group entered the Bangladesh logistics market in 2012 and has expanded the business primarily through providing international forwarding services, focusing on the apparel industry. Now, in response to growing demand for domestic logistics services and to expand its customer base in Bangladesh, the NX Group has decided to further strengthen its domestic logistics operations in the country. CCBL, headquartered in Dhaka, Bangladesh, is a third-party logistics company specializing in domestic distribution logistics. CCBL has a nationwide logistics infrastructure with the capabilities for handling all types of goods, including those requiring temperature-controlled storage and transportation. The NX Group's strategy is to strengthen its domestic Bangladesh logistics business by leveraging CCBL's domestic logistics network and assets, thereby capturing logistics opportunities arising from growing domestic demand. Further, by leveraging its global logistics network, including forwarding, the NX Group will provide end-to-end solutions for its customers' supply chains. The NX Group aims to realize growth opportunities in Bangladesh at an early stage through this investment in the Bangladesh logistics market, thereby contributing to value creation for its customers and stakeholders. Overview of CCBL(1) Company Name: Cold Chain Bangladesh Limited(2) Headquarters Address: Shanta Western Tower, Level-5, 501 & 502, 186, Gulshan-Tejgaon Link Road, Tejgaon I/A, Dhaka-1208(3) Sites and Facilities:- 13 sites in 10 cities in Bangladesh (with temperature-controlled storage, see site map below)- 50 vehicles (including temperature-controlled vehicles)(4) Representative: Rezaul Alam, President and CEO(5) Business: Logistics (warehouse deliveries, domestic truck transportation) and other value-added services Site map: About the NX Group: NX Group official website: NX Group's official LinkedIn account: View original content: SOURCE NIPPON EXPRESS HOLDINGS, INC.
Yahoo
14-04-2025
- Business
- Yahoo
Japan Biopharmaceutical Logistics Market to Worth Over US$ 12.20 Billion by 2033
Japan's biopharmaceutical logistics market is propelled by demand for temperature-sensitive advanced therapies, regulatory modernization, and regenerative medicine export goals. Emphasis on sustainable infrastructure and precision logistics addresses ultra-cold storage and trial complexity. Chicago, April 14, 2025 (GLOBE NEWSWIRE) -- According to recent analysis conducted by Astute Analytica, the Japan biopharmaceutical logistics market was valued at US$ 6.34 billion in 2024 and is expected to reach US$ 12.21 billion by 2033, growing at a CAGR of 7.77% during the forecast period 2025-2033. Japan's biopharmaceutical logistics market is expanding due to its rapidly aging population, with over 29% aged 65+ as of 2024. This demographic shift fuels demand for biologics, including monoclonal antibodies and vaccines, which require stringent temperature-controlled logistics. The market, valued at $2.8 billion in 2023, is projected to grow at a 7.3% CAGR through 2030, driven by therapies for cancer, diabetes, and rare diseases. Regulatory emphasis on precision in storage (2°C–8°C for most biologics) and transport has intensified, with deviations causing 15% of product spoilage in 2022. Major logistics firms like Nippon Express and Kintetsu World Express now allocate 30% of cold chain capacity to biopharma, up from 18% in 2020. Additionally, 62% of hospitals now mandate real-time temperature tracking for biologics, up from 45% in 2021. Government initiatives, including subsidies for cold chain infrastructure, aim to reduce spoilage costs, which hit $240 million annually in 2023. Collaborations between pharma giants (e.g., Takeda) and logistics providers to deploy IoT-enabled containers have reduced transit errors by 22% since 2022. Download Free Sample Pages: Key Findings in Japan Biopharmaceutical Logistics Market Market Forecast (2033) US$ 12.21 million CAGR 7.77% By Logistics Type Cold Chain Logistics (71.76%) By Service Type Transportation Service (43.53%) By Product Type Vaccine (30.03%) By Mode of Transportation Air Transport (50.83%) By End User Pharmaceutical & Biotech Companies (54.80%) Top Drivers Aging population (30% >65) driving biologics demand for chronic diseases. Gene therapy regulatory reforms (PMDA 2023 guidelines) spurring clinical trial logistics. Export-focused regenerative medicine (iPSC therapies) requiring global GDP compliance. Top Trends AI-driven rural cold chain hubs for decentralized home healthcare distribution. Solar-powered warehousing + hybrid refrigerated trucks meeting 2050 net-zero mandates. Blockchain-IoT platforms minimizing biologics spoilage via real-time predictive analytics. Top Challenges Talent shortages in GDP-compliant ultra-cold (-80°C) logistics operations. High costs of precision infrastructure for small-batch advanced therapies. Cross-border standardization gaps between Japan's J-GDP and global CEIV protocols. Regulatory overhauls Shape Biopharma Logistics Compliance and Innovation Japan's Pharmaceuticals and Medical Devices Agency (PMDA) enforced revised GDP guidelines in April 2024, mandating blockchain for temperature data integrity and stricter audit trails. Non-compliance fines in the biopharmaceutical logistics market now exceed $500,000 per violation, up from $200,000 pre-2023. These rules align with ICH Q12 standards, requiring 99.5% temperature accuracy for biologics during transit. Logistics providers have invested $380 million in AI-powered predictive analytics to preempt equipment failures, reducing delays by 18% in Q1 2024. The PMDA's 'Green Cold Chain' initiative also incentivizes eco-friendly practices, with 25% tax rebates for firms using sustainable refrigerants like CO2-based systems. Additionally, the 2024 Biologics Safety Act requires real-time GPS tracking for high-value shipments (e.g., gene therapies), which constitute 12% of Japan's biopharma logistics volume. Custom brokers report a 30% rise in licenses for specialized biopharma transporters since 2022, reflecting heightened compliance complexities. Despite this, 40% of small logistics firms struggle to upgrade legacy systems, creating consolidation opportunities for giants like Sagawa Express. Cold Chain Infrastructure Investments Address Urban-Rural Distribution Gaps Japan's biopharmaceutical logistics market providers are racing to close urban-rural cold chain gaps, with 75% of advanced biologics distributed in Tokyo, Osaka, and Nagoya as of 2024. Rural areas face 23% longer delivery times, risking product efficacy. To counter this, Yamato Holdings launched 12 regional hubs in 2023 with -20°C storage, expanding reach to 88% of prefectures. The government's $1.2 billion Bio-Logistics Corridor project, active since 2022, funds drone deliveries for remote regions, cutting vaccine shipment times by 35%. Cold chain storage capacity grew 19% YoY in 2024, hitting 12.3 million cubic meters, yet demand outpaces supply by 8%. Mitsubishi Logistics now uses autonomous EVs with solar-powered refrigeration, reducing energy costs by 27%. However, rural clinics still experience 14% more temperature excursions than urban counterparts, per 2024 MHLW data. Partnerships with local pharmacies for 'last-mile' biologics storage have increased 40% since 2023, though scalability remains challenged by Japan's mountainous terrain. Strategic Alliances and M&A Reshape Market Competitive Dynamics The Japanese biopharmaceutical logistics market has been transformed by specific strategic moves, as evidenced by the Q3 2024 data showing 22 pharmaceutical M&A deals valued at $512.7 million. A notable technological implementation comes from the TriNetX-Fujitsu joint venture, which has established TriNetX Japan K.K., integrating the TriNetX LIVE™ platform that connects over 200 million patient records with Fujitsu's specialized healthcare cloud platform. This joint venture has implemented a federated system specifically designed to comply with Japan's stringent data privacy regulations, enabling secure handling of anonymous patient data for research purposes. The collaboration has directly impacted drug development timelines through the utilization of anonymized EHR data, particularly beneficial for Japan's aging population studies. The market dynamics of the Japan biopharmaceutical logistics market are further shaped by specific regulatory developments, particularly the Economic Security Bill's classification of pharmaceutical goods as "critical items." While major players like Nippon Express and DHL Logistics are adapting to these regulations, specific compliance measures from these companies are still being developed and implemented. The broader M&A landscape in early 2024 shows a trend toward smaller-scale acquisitions, with the Asia-Pacific region experiencing a 24% year-on-year decrease in transaction volume, totaling $132 billion. This trend is reflected in the biopharma sector's Q4 2024 median deal value of $800 million. The TriNetX-Fujitsu partnership specifically addresses social issues through Fujitsu's "Fujitsu Uvance" business model, which aims to eliminate drug loss in Japan by creating an ecosystem that effectively leverages medical data. These specific developments indicate a market shift toward technology-driven partnerships and smaller, more strategic acquisitions rather than large-scale consolidations. Have questions? Inquire about this report before purchasing: Advanced Technology Integration Enhances Supply Chain Visibility and Efficiency Japan's biopharmaceutical logistics market is leveraging cutting-edge technologies to mitigate risks in temperature-sensitive shipments, with AI and blockchain adoption surging 47% since 2022. Real-time monitoring systems now cover 78% of biologics shipments as of Q1 2024, up from 52% in 2021, driven by Pharma 4.0 initiatives from METI. These systems reduce human intervention by automating temperature adjustments, slashing excursion rates to 3.2% in 2024 from 8.5% in 2020. Blockchain's immutable ledger usage has grown exponentially, with 65% of logistics firms integrating it for audit trails, ensuring compliance with PMDA's revised Good Distribution Practices (GDP). For instance, Mitsui & Co.'s collaboration with IBM Japan in 2023 enabled end-to-end data transparency for mRNA vaccines, reducing regulatory approval delays by 30%. Today, IoT-enabled smart pallets, deployed by 40% of third-party logistics (3PL) providers in the biopharmaceutical logistics market, predict maintenance needs using vibration sensors, lowering equipment downtime by 25%. Meanwhile, AI-driven route optimization tools, like NEC's 2024 Cloud Logistics Platform, cut fuel costs by 18% while maintaining 99.1% on-time delivery rates for biologics. This tech convergence is critical as Japan's biopharma imports rise (up 22% YoY in 2024), demanding seamless coordination between ports, airports, and inland hubs. Sustainability Initiatives Reshape Cold Chain Energy Consumption and Design Japanese firms active in the biopharmaceutical logistics market face mounting pressure to decarbonize, with cold chains contributing 12% of the sector's carbon emissions in 2023. The 2024 Revised Energy Conservation Act mandates a 30% reduction per shipment by 2030, spurring investments in renewable energy-powered warehouses. Solar-equipped cold storage facilities, like those operated by Konoike Transport, now cover 15% of national capacity, up from 4% in 2020, reducing grid dependence by 40%. Hydrogen fuel cell refrigeration units, piloted by JR Freight in 2023, cut per-truck emissions by 58% and are slated for nationwide rollout by 2025. Biodegradable phase-change materials (PCMs), adopted by 28% of packagers, extend temperature stability by 20% while reducing polystyrene waste, which previously comprised 35% of packaging debris. The PMDA's 'Green Label' certification, introduced in 2024, grants tax breaks to companies achieving full circularity in cold chain packaging—a standard met by only 9% of firms so far in the biopharmaceutical logistics market. Challenges persist, however: sustainable refrigerants like CO2 and ammonia cost 22% more than traditional fluorinated gases, squeezing mid-sized players. To bridge this gap, METI's $150 million Green Cold Chain Fund offers low-interest loans, spurring a 65% jump in eco-upgrades since 2023. Talent Shortages and Automation Define Workforce Strategies in Biopharma Logistics A crippling 34% shortage of qualified cold chain technicians in 2024 is accelerating automation across Japan's biopharmaceutical logistics market. The gap stems from an aging workforce—35% of specialists will retire by 2027—and insufficient STEM graduates entering the field (only 12% in 2023 vs. 21% in South Korea). Firms like Sagawa Express are responding by deploying AI-guided robotics in 60% of warehouses, up from 18% in 2021, to handle labeling, sorting, and inventory. Autonomous forklifts, integrated with digital twins, have reduced loading errors by 44% at Nippon Express's Osaka hub since 2023. Meanwhile, augmented reality (AR) tools train new hires 50% faster by simulating temperature excursion scenarios, addressing the 6-month backlog in certification programs. The government's 2024 Robotics Subsidy Program offsets 25% of automation costs, prompting a 300% spike in collaborative robot (cobot) installations for QC tasks. Yet, human oversight remains critical: PMDA mandates at least one GDP-certified supervisor per shipment, creating demand for hybrid roles blending tech and regulatory skills. Salaries for such roles rose 19% in 2024, reflecting fierce competition, but attrition rates still hover at 14% due to high stress. Pandemic Preparedness and Stockpiling Reshape Inventory Management Priorities Japan's post-pandemic biopharmaceutical logistics market strategies prioritize redundancy, with the National Health Ministry doubling vaccine stockpiles to 240 million doses in 2024. This follows 2021's influenza-COVID co-circulation crisis, which exposed vulnerabilities in just-in-time inventory models, causing 23% of clinics to report biologic shortages. Distributed storage models now dominate, with 65% of firms using multi-location hubs (vs. 38% in 2021) to insulate against regional disruptions like Typhoon Hagibis II in 2024, which halted Kansai-area deliveries for 72 hours. AI-driven demand forecasting tools, such as Fujitsu's Biologics Inventory Optimizer, dynamically adjust stock levels, reducing overstock waste by 31% while maintaining 98% fill rates. The PMDA's new 'Resilience Index' rating, mandatory since April 2024, grades logistics providers in the biopharmaceutical logistics market on backup power capacity (+20% YoY growth in generator-equipped warehouses) and alternative transport contracts. Partnerships with airlines like ANA and JAL now guarantee 36% of biologics airfreight capacity during emergencies, up from 15% pre-pandemic. However, smaller hospitals still lack onsite mRNA freezer farms, relying on 3PLs for 89% of ultra-cold chain needs—a dependency that spiked costs by 18% during 2024's RSV vaccine rush. Japan Biopharmaceutical Logistics Market Major Players: Cencora Corporation (World Courier) ITOCHU Logistics Corp Nippon Express Co., Ltd DHL International GmbH United Parcel Service of America, Inc. Mitsubishi Logistics Corporation GREEN8 Co., Ltd. Other Prominent Players Key Segmentation: By Logistics Type Cold Chain Logistics Non- Cold Chain Logistics By Service Type Storage Service Transportation Service Packaging Service Monitoring and Tracking Service By Product Type Vaccines Blood Products Specialty Drug Monoclonal Antibodies Others By Mode of Transportation Air Transport Ground Transport Water Transport By End User Pharmaceutical & Biotech Companies Academic & Research Institutions Hospitals and Specialty Clinics Others Looking for expert insights? Request an online presentation of the report from our analyst: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in to access your portfolio
Japan Times
14-03-2025
- Business
- Japan Times
Watchdog finds Dentsu and other Japanese firms reluctant to accept price hikes
Advertising giant Dentsu and two other Japanese companies have been found to be reluctant to accept price hikes by their business partners, the Japan Fair Trade Commission said Friday. Dentsu, transportation service company Nippon Express and home center operator Kohnan Shoji have kept their transaction prices with their partners unchanged without consultation despite rising raw materials and other costs, the antitrust watchdog said. The FTC will urge the three to improve their practices, including by holding talks on prices with their business partners. The commission hopes to help companies pass rising costs on to their clients appropriately to make it easier for them to raise the salaries of their workers.
Yahoo
17-02-2025
- Business
- Yahoo
NX Taiwan Becomes First Japanese Company to Receive QMS Certification for Medical Devices at Its NEXT3 Warehouse in Taoyuan City
TOKYO, Feb. 17, 2025 /PRNewswire/ -- Nippon Express (Taiwan) Co., Ltd. (hereafter "NX Taiwan"), a group company of NIPPON EXPRESS HOLDINGS, INC., obtained certification on Wednesday, December 18, 2024 from the Taiwan Food and Drug Administration (TFDA) for the quality management system (QMS) established at its NEXT3 warehouse in the northern Taiwanese city of Taoyuan to ensure the quality and safety of medical devices (hereafter "medical device QMS certification"), the first such certification acquired by a Japanese company. Logo: Exterior view of warehouse: Taiwan has been tightening quality control of medical devices by, for example, requiring certification for packaging and affixing Chinese labels to medical devices imported into Taiwan from May 1, 2021. The NEXT3 warehouse acquired good distribution practice (GDP) and good manufacturing practice (GMP) certification for pharmaceuticals in April 2022 and GMP certification for cosmetics in February 2024. With the newly acquired medical device QMS certification, the warehouse is now capable of storing and processing medical devices in compliance with quality control standards, both services expected to see rising demand in future. Equipped with air-conditioned storage and processing work areas, the warehouse enjoys a very suitable location for international logistics, being situated 15 km from Taoyuan International Airport, 32 km from Taipei Port, 53 km from Keelung Port, and close to the Nangang Interchange on the north-south Highway 1 traversing Taiwan. This latest certification will enable the facility to provide high-quality services to more customers. The NX Group will be further expanding its logistics functions within Taiwan as well as its international transport services utilizing the Group's global network to help customers enhance their business activities and thereby realize its own long-term vision of becoming a logistics company with a strong presence in the global market. Certification detailsName of certified organization: Nippon Express (Taiwan) Co., date: Wednesday, December 18, 2024Facility: Nippon Express (Taiwan) Co., Ltd., NEXT3 warehouseCertification: Medical device QMS certificationCertification body: Taiwan Food and Drug Administration (TFDA)Certified services: Packaging and labeling of medical devices About the NX Group: NX Group official website: NX Group's official LinkedIn account: View original content: SOURCE NIPPON EXPRESS HOLDINGS, INC. Sign in to access your portfolio
